Hunan Fangsheng EBITDA vs. Current Valuation
| 603998 Stock | 11.49 0.21 1.86% |
EBITDA | First Reported 2010-12-31 | Previous Quarter 492 M | Current Value 516.6 M | Quarterly Volatility 144.6 M |
For Hunan Fangsheng profitability analysis, we use financial ratios and fundamental drivers that measure the ability of Hunan Fangsheng to generate income relative to revenue, assets, operating costs, and current equity. These fundamental indicators attest to how well Hunan Fangsheng Pharm utilizes its assets to generate profit and value for its shareholders. The profitability module also shows relationships between Hunan Fangsheng's most relevant fundamental drivers. It provides multiple suggestions of what could affect the performance of Hunan Fangsheng Pharm over time as well as its relative position and ranking within its peers.
Hunan |
Hunan Fangsheng Pharm Current Valuation vs. EBITDA Fundamental Analysis
Comparative valuation techniques use various fundamental indicators to help in determining Hunan Fangsheng's current stock value. Our valuation model uses many indicators to compare Hunan Fangsheng value to that of its competitors to determine the firm's financial worth. Hunan Fangsheng Pharm is number one stock in ebitda category among its peers. It also is the top company in current valuation category among its peers reporting about 20.88 of Current Valuation per EBITDA. At present, Hunan Fangsheng's EBITDA is projected to increase significantly based on the last few years of reporting. Comparative valuation analysis is a catch-all model that can be used if you cannot value Hunan Fangsheng by discounting back its dividends or cash flows. This model doesn't attempt to find an intrinsic value for Hunan Fangsheng's Stock. Still, instead, it compares the stock's price multiples to a benchmark or nearest competition to determine if the stock is relatively undervalued or overvalued.Hunan Current Valuation vs. EBITDA
EBITDA stands for earnings before interest, taxes, depreciation, and amortization. It is a measure of a company operating cash flow based on data from the company income statement and is a very good way to compare companies within industries or across different sectors. However, unlike Operating Cash Flow, EBITDA does not include the effects of changes in working capital.
Hunan Fangsheng |
| = | 265.42 M |
In a nutshell, EBITDA is calculated by adding back each of the excluded items to the post-tax profit, and can be used to compare companies with very different capital structures.
Enterprise Value is a firm valuation proxy that approximates the current market value of a company. It is typically used to determine the takeover or merger price of a firm. Unlike Market Cap, this measure takes into account the entire liquid asset, outstanding debt, and exotic equity instruments that the company has on its balance sheet. When a takeover occurs, the parent company will have to assume the target company's liabilities but will take possession of all cash and cash equivalents.
Hunan Fangsheng |
| = | 5.54 B |
Enterprise Value can be a useful tool to compare companies with different capital structures. Long term liability and current cash or cash equivalents can have a huge impact on market valuation of a given company.
Hunan Current Valuation vs Competition
Hunan Fangsheng Pharm is the top company in current valuation category among its peers. After adjusting for long-term liabilities, total market size of Health Care industry is presently estimated at about 4.61 Trillion. Hunan Fangsheng adds roughly 5.54 Billion in current valuation claiming only tiny portion of equities under Health Care industry.
Hunan Fangsheng Profitability Projections
The most important aspect of a successful company is its ability to generate a profit. For investors in Hunan Fangsheng, profitability is also one of the essential criteria for including it into their portfolios because, without profit, Hunan Fangsheng will eventually generate negative long term returns. The profitability progress is the general direction of Hunan Fangsheng's change in net profit over the period of time. It can combine multiple indicators of Hunan Fangsheng, where stable trends show no significant progress. An accelerating trend is seen as positive, while a decreasing one is unfavorable. A rising trend means that profits are rising, and operational efficiency may be rising as well. A decreasing trend is a sign of poor performance and may indicate upcoming losses.
| Last Reported | Projected for Next Year | ||
| Operating Income | 204.4 M | 125.2 M | |
| Income Before Tax | 203.3 M | 126.1 M | |
| Net Income Applicable To Common Shares | 328.7 M | 345.2 M | |
| Net Income | 186.8 M | 105.8 M | |
| Income Tax Expense | 57.4 M | 60.2 M | |
| Net Income From Continuing Ops | 179.6 M | 119 M | |
| Total Other Income Expense Net | 781.7 K | 742.6 K | |
| Net Interest Income | -10.8 M | -11.4 M | |
| Interest Income | 10.6 M | 11.2 M | |
| Change To Netincome | -114.8 M | -109.1 M |
Hunan Profitability Driver Comparison
Profitability drivers are factors that can directly affect your investment outlook on Hunan Fangsheng. Investors often realize that things won't turn out the way they predict. There are maybe way too many unforeseen events and contingencies during the holding period of Hunan Fangsheng position where the market behavior may be hard to predict, tax policy changes, gold or oil price hikes, calamities change, and many others. The question is, are you prepared for these unexpected events? Although some of these situations are obviously beyond your control, you can still follow the important profit indicators to know where you should focus on when things like this occur. Below are some of the Hunan Fangsheng's important profitability drivers and their relationship over time.
Use Hunan Fangsheng in pair-trading
One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Hunan Fangsheng position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Hunan Fangsheng will appreciate offsetting losses from the drop in the long position's value.Hunan Fangsheng Pair Trading
Hunan Fangsheng Pharm Pair Trading Analysis
The ability to find closely correlated positions to Hunan Fangsheng could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Hunan Fangsheng when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Hunan Fangsheng - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Hunan Fangsheng Pharm to buy it.
The correlation of Hunan Fangsheng is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Hunan Fangsheng moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Hunan Fangsheng Pharm moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Hunan Fangsheng can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.Use Investing Themes to Complement your Hunan Fangsheng position
In addition to having Hunan Fangsheng in your portfolios, you can quickly add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your investment opportunity, you can then find an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility.Did You Try This Idea?
Run Books Thematic Idea Now
Books
Companies involved in publishing of books, newspapers, periodicals and other mass publications. The Books theme has 48 constituents at this time.
You can either use a buy-and-hold strategy to lock in the entire theme or actively trade it to take advantage of the short-term price volatility of individual constituents. Macroaxis can help you discover thousands of investment opportunities in different asset classes. In addition, you can partner with us for reliable portfolio optimization as you plan to utilize Books Theme or any other thematic opportunities.
| View All Next | Launch |
Other Information on Investing in Hunan Stock
To fully project Hunan Fangsheng's future profitability, investors should examine all historical financial statements. These statements provide investors with a comprehensive snapshot of the financial position of Hunan Fangsheng Pharm at a specified time, usually calculated after every quarter, six months, or one year. Three primary documents fall into the category of financial statements. These documents include Hunan Fangsheng's income statement, its balance sheet, and the statement of cash flows.